These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6201049)

  • 1. Endotoxins and coagulation parameters in patients with traumatic haemorrhagic- and bacteriotoxic shock.
    Stemberger A; Strasser F; Blümel G; von Hundelshausen B; Jelen S; Schmidt O; Tempel G
    Adv Exp Med Biol; 1984; 167():439-48. PubMed ID: 6201049
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteases and antiproteases in experimental low-flow states.
    Massion WH; Peschl L; Blümel G
    Adv Exp Med Biol; 1971 Oct; 23(0):381-92. PubMed ID: 5317478
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular (thrombocytes, granulocytes) effects of proteinase inhibitors--gabexylate, gabexate mesilate (FOY) and aprotinin.
    Redl H; Schlag G; Paul E; Schiesser A
    Resuscitation; 1986 Sep; 14(1-2):81-90. PubMed ID: 2431445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversibility in shock: role of vasoactive kinins.
    Massion WH; Blümel G
    Anesth Analg; 1971; 50(6):970-6. PubMed ID: 5316075
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes of serum amino acid concentrations in experimentally induced endotoxic shock. The significance of hyperalaninemia in the prediction of lethality.
    Metzler B; Rettenmeier AW; Wodarz I; Schmahl FW
    Prog Clin Biol Res; 1989; 308():595-9. PubMed ID: 2506574
    [No Abstract]   [Full Text] [Related]  

  • 6. Nafamostat mesilate, a synthetic protease inhibitor, attenuated hypercoagulability in a canine model of hemorrhagic shock.
    Koido Y; Kato K; Shimizu-Suganuma M; Shichinohe K
    Nihon Ika Daigaku Zasshi; 1997 Feb; 64(1):9-15. PubMed ID: 9119959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of Trasylol on experimental endotoxic shock and hemorrhagic necrosis of the intestine].
    Wiznitzer T; Loewenthal M; Michowitz M; Wishnievsky M
    Harefuah; 1973 Apr; 84(7):368-72. PubMed ID: 4541102
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of FOY on lysosomes in hemorrhagic hypotension--a histological analysis].
    Miyawaki T; Sameshima T; Miyao J; Oda T
    Masui; 1984 Mar; 33(3):263-8. PubMed ID: 6429387
    [No Abstract]   [Full Text] [Related]  

  • 9. FOY: [ethyl p-(6-guanidinohexanoyloxy) benzoate] methanesulfonate as a serine proteinase inhibitor. II. In vivo effect on coagulofibrinolytic system in comparison with heparin or aprotinin.
    Ohno H; Kambayashi J; Chang SW; Kosaki G
    Thromb Res; 1981 Dec 1-15; 24(5-6):445-52. PubMed ID: 6178174
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular and metabolic effects of shock.
    Hardaway RM
    J Am Vet Med Assoc; 1979 Jul; 175(1):81-6. PubMed ID: 387685
    [No Abstract]   [Full Text] [Related]  

  • 11. What mechanisms influence oxygen transport and oxygen tissue delivery in endotoxic and hemorrhagic shock?
    Gump FE
    Adv Exp Med Biol; 1971 Oct; 23(0):167-75. PubMed ID: 5164860
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitory effects of gabexate mesilate (FOY) on experimental DIC.
    Isobe J
    Adv Exp Med Biol; 1979; 120B():385-94. PubMed ID: 229708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effects of protease inhibitors on glioma cells in culture].
    Obonai C
    Nihon Gan Chiryo Gakkai Shi; 1988 Aug; 23(8):1720-6. PubMed ID: 2461424
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of protease inhibitors in experimental septic shock.
    Siebeck M; Spannagl M; Hoffmann H; Fink E
    Agents Actions Suppl; 1992; 38 ( Pt 3)():421-7. PubMed ID: 1281381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: Role of endotoxin and complement in shock.
    N Engl J Med; 1974 Apr; 290(15):860. PubMed ID: 4817846
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitory effect of aprotinin and gabexate mesilate on human plasma kallikrein.
    Nakahara M
    Arzneimittelforschung; 1983; 33(7):969-71. PubMed ID: 6194800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of aprotinin, a protease inhibitor, on porcine E. coli shock. Studies on coagulation, fibrinolytic and hemodynamic response.
    Svartholm E; Haglund U; Ljungberg J; Hedner U
    Acta Chir Scand; 1989; 155(1):7-13. PubMed ID: 2467477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of various drugs and fluid on the blood coagulation- fibrinolysis and kinin systems in canine hemorrhagic shock].
    Hatano K
    Masui; 1985 May; 34(5):637-48. PubMed ID: 2411958
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticoagulant release during shock.
    Maki M; Nagayama M; Oda T; Shinagawa S
    Thromb Res; 1976 May; 8(2 suppl):159-63. PubMed ID: 1084586
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyrotropin-releasing hormone improves cardiovascular function in experimental endotoxic and hemorrhagic shock.
    Holaday JW; D'Amato RJ; Faden AI
    Science; 1981 Jul; 213(4504):216-8. PubMed ID: 6787704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.